ArticleOncotarget2019

SMR peptide antagonizes mortalin promoted release of extracellular vesicles and affects mortalin protection from complement-dependent cytotoxicity in breast cancer cells and leukemia cells.

Ming-Bo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.